openPR Logo
Press release

Intravenous Solution Market worth USD 11,511.2 Million At ~7.69 % of CAGR By 2022

10-26-2017 07:24 PM CET | Health & Medicine

Press release from: Market Research Future

Intravenous Solution Market worth USD 11,511.2 Million At ~7.69

Market Research Future published a Cooked research report on “Intravenous (IV) Solution Market Research Report- Global Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022.

Intravenous Solution Market Study By Type, Key Companies, End User & is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69%

Market Synopsis of Global Intravenous (IV) Solution Market:
Market Scenario:
Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls. Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.
The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer.

Get a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/1235

Key Players for Global Intravenous (IV) Solution Market:
• ICU Medical, Inc. (U.S.)
• B. Braun Melsungen
• AG (Germany)
• Fresenius Kabi AG (Germany)
• Baxter (U.S.)
• Amanta Healthcare (India)
• Terumo Medical Corporation (Tokyo)
• Grifols S.A. (Spain)

Key Finding
The global Intravenous (IV) Solution market and is expected to reach USD 11,511.2 million by 2022By type, Total Parenteral Nutrition (TPN) holds the largest market share of global Intravenous (IV) Solution market and is expected to reach USD 4,940.0 million in 2016By nutritional content, amino acid solution holds the largest market share of global Intravenous (IV) Solution market is expected to reach USD 2,385.0 million in 2016

Segments:
Global Intravenous (IV) Solution Market has been segmented on the basis of type which comprises of total parenteral solution, peripheral parenteral solution. On the basis of nutritional content the market is segmented into amino acid solution, carbohydrates, vitamins & minerals, parenteral lipid emulsion and others. On the basis of end user the market is segmented into hospitals & clinics, ambulatory and home care.
Regional Analysis of Global Intravenous (IV) Solution Market:
The global market for Intravenous (IV) Solution is growing rapidly. The market for Intravenous (IV) Solution is growing with the CAGR of 7.69% during the forecast period from 2016-2022. North America accounts for largest market share in 2015 and is expected to reach USD 4,276.5 million in 2016. This growth is attributed to the factors such as high IV consumption number, high prevalence of chronic diseases.
Asia-Pacific region is the fastest growing market for real time health monitoring devices, which is expected to grow at a CAGR of 8.34% during the forecast period from 2016 to 2022 is due to the emergence of high-quality and better healthcare infrastructure and institutions in this region.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/intravenous-solution-market

The report for Global Intravenous (IV) Solution Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Continue…
We are thankful for the support and assistance from Intravenous (IV) Solution Market Research Report- Global Forecast to 2022 chain related technical experts and marketing experts during Research Team survey and interviews.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intravenous Solution Market worth USD 11,511.2 Million At ~7.69 % of CAGR By 2022 here

News-ID: 788815 • Views:

More Releases from Market Research Future

Global Stem Cell Assay Market Set to Reach USD 10.27 Billion by 2035 as Regenerative Medicine and Drug Discovery Enter New Era
Global Stem Cell Assay Market Set to Reach USD 10.27 Billion by 2035 as Regenera …
The global Stem Cell Assay Market is experiencing a period of exponential growth, fueled by the rapid expansion of regenerative medicine and a surging demand for physiologically relevant models in drug toxicity testing. According to recent industry analysis for 2026, the market is valued at approximately USD 5.04 billion and is projected to reach USD 10.27 billion by 2035, exhibiting a robust compound annual growth rate (CAGR) of 8.22%. As pharmaceutical
Global Healthcare IT Market Projected to Surpass USD 1,650.34 billion by 2035, Catalyzed by Generative AI and Cloud-Native Ecosystems
Global Healthcare IT Market Projected to Surpass USD 1,650.34 billion by 2035, C …
The global Healthcare IT Market is entering a new era of hyper-growth, driven by the mass adoption of generative AI, the decentralization of patient care, and a critical industry-wide push for data interoperability. According to the latest market intelligence, the sector is valued at approximately USD 386.58 billion in 2026 and is forecasted to accelerate at a remarkable compound annual growth rate (CAGR) of 17.5%, reaching USD 1,650.34 billion by
Global Medical Foods Market Poised to Reach USD 40.77 Billion by 2035, Driven by Personalized Nutrition and Chronic Disease Management
Global Medical Foods Market Poised to Reach USD 40.77 Billion by 2035, Driven by …
The global Medical Foods Market is undergoing a significant transformation, fueled by a paradigm shift in healthcare toward specialized, condition-specific nutritional interventions. According to the latest industry analysis, the market was valued at approximately USD 24.04 billion in 2024 and is projected to expand at a steady compound annual growth rate (CAGR) of 4.92%, reaching a staggering USD 40.77 billion by 2035. Medical foods, which are specifically formulated for the dietary
Hybrid Operating Room Market Projected to Reach $1.504 Billion by 2035, Driven by Advanced Imaging Integration and Minimally Invasive Surgery Demand
Hybrid Operating Room Market Projected to Reach $1.504 Billion by 2035, Driven b …
Global Market Analysis Reveals 6.79% CAGR Growth Fueled by Technological Innovation and Enhanced Surgical Precision Requirements The global Hybrid Operating Room Market is experiencing steady expansion, with market valuation projected to grow from $0.73 billion in 2024 to $1.504 billion by 2035, according to comprehensive market research conducted by Market Research Future. This significant growth represents a compound annual growth rate of 6.79% throughout the forecast period from 2025 to 2035,

All 5 Releases


More Releases for Intravenous

Rising Cancer Prevalence Driving The Intravenous Solutions Market: Critical Driv …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Intravenous Solutions Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market for intravenous solutions has experienced robust expansion recently and is projected to increase from $14 billion in 2024 to $14.91 billion in 2025, reflecting a compound annual growth rate of 6.5%; this upward
Future Outlook of the Soliris Intravenous Market: Soliris Intravenous Trends and …
The global Soliris Intravenous Market was valued at approximately USD 3.5 billion in 2024 and is projected to reach around USD 6.8 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033. Request a sample copy of this report at: https://www.omrglobal.com/request-sample/soliris-intravenous-market Soliris Intravenous Market Overview: The Soliris Intravenous Market is experiencing steady growth driven by the increasing prevalence of rare and chronic diseases such as
Intravenous Iron Drugs Market
The "Intravenous Iron Drugs Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Intravenous Iron Drugs Market, 2024-2031 Verified Market Research's most recent report, "Intravenous Iron Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides
Intravenous (IV) Solutions Market
The Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. Key Finding The global Intravenous (IV) Solution market and is expected to reach USD
Intravenous Solutions Market Opportunity Analysis, 2026
Intravenous solutions are the chemically prepared fluids, which are administered in the body through venous circulation to maintain or replace the lost body fluid level. There are various types of IV solutions that have different effects on a human body. Majority of intravenous solutions constitute of solvent and solute out of which solvents are sterile water and solutes are electrolytes such as sodium, potassium, and chloride. Intravenous solutions market is
Intravenous Product Packaging Market -
Global healthcare sector continues to develop at an impressive rate. As a result, packaging marketplace is undergoing huge changes with specialized focus on offering innovative packaging tools/products to pharmaceutical industry. One such core product that offers lucrative market opportunities for packaging companies is intravenous products. Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14075 Intravenous product such as catheters and IV fluid bags are mainly used to prevent and treat various chronic illness